Status:
RECRUITING
A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
Hong Kong Children's Hospital
Conditions:
Pediatrics Cancer
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Sleep is essential for a child's development, influencing cognitive function, emotional stability, recovery, and overall well-being. Prolonged and intensive treatments for pediatric oncology patients ...
Detailed Description
The trial employs a prospective, single-blind, waitlist-controlled design with 1:1 allocation. Block randomization, generated by computer and concealed in sealed opaque envelopes, ensures balanced gro...
Eligibility Criteria
Inclusion Criteria:
- Children who can read and communicate in Chinese
- Aged 6 to 12 years old (school-aged children).
- Diagnosed with cancer and currently undergoing active treatment.
- Identified as experiencing sleep disturbances, defined by a Chinese Pittsburgh Sleep Quality Index (PSQI) global score of ≥5.
Exclusion Criteria:
- Diagnosed with hematological diseases unrelated to cancer (e.g., sickle cell anemia, thalassemia).
- Presence of severe cognitive impairment, which may hinder the ability to follow instructions or engage with intervention components.
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT07323069
Start Date
September 15 2025
End Date
July 1 2027
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hong Kong Children's Hospital
Kowloon Bay, Hong Kong